From: Socioeconomic environment and cancer incidence: a French population-based study in Normandy
Site | Moran test | PW test | Estimationa | CIb(95%) | Exp (β) |
---|---|---|---|---|---|
p-value | p-value | EDI coefficient | |||
Prostate | 0.33 | < 0.05 | -0.023 | [-0.043 ; -0.010] | 0.98 |
Lung | < 0.025 | < 0.05 | 0.087 | [0.065 ; 0.108] | 1.09 |
Colon-rectum | < 0.025 | < 0.05 | 0.025 | [-0.001; 0.050] | |
Lips-mouth-pharynx | < 0.025 | < 0.05 | 0.149 | [0.122 ; 0.176] | 1.16 |
Bladder | < 0.025 | < 0.05 | 0.033 | [0.001 ; 0.064] | 1.03 |
Kidney | <0.025 | < 0.05 | 0.033 | [-0.003; 0.069] | |
Stomach | < 0.025 | < 0.05 | 0.001 | [-0.047; 0.047] | |
Liver | < 0.025 | < 0.05 | 0.076 | [0.039 ; 0.114] | 1.08 |
Esophagus | < 0.025 | < 0.05 | 0.086 | [0.043; 0.131] | 1.09 |
Non-Hodgkin lymphoma | 0.04 | < 0.05 | -0.006 | [-0.047; 0.035] | |
Unknown primary sites | 0.11 | < 0.05 | 0.060 | [0.019 ; 0.101] | 1.06 |
Larynx | < 0.025 | < 0.05 | 0.154 | [0.114; 0.196] | 1.17 |
Pancreas | 0.65 | < 0.05 | 0.019 | [-0.029; 0.066] | |
Melanoma | 0.86 | < 0.05 | -0.078 | [-0.132; -0.026] | 0.92 |
Central nervous system | < 0.025 | < 0.05 | 0.056 | [0.010; 0.101] | 1.06 |
Myeloma | 0.84 | < 0.05 | -0.024 | [-0.080; 0.030] | |
Lymphocytic leukemia | 0.98 | < 0.05 | -0.040 | [-0.105; 0.023] | |
Testis | < 0.025 | < 0.05 | -0.029 | [-0.094; 0.036] | |
Leukemia | 0.43 | < 0.05 | -0.013 | [-0.080; 0.052] | |
Thyroid | 0.09 | < 0.05 | 0.020 | [-0.057; 0.095] | |
Hodgkin’s lymphoma | 0.16 | < 0.05 | -0.085 | [-0.180; 0.005] | |
Gall-bladder and | < 0.025 | < 0.05 | 0.141 | [0.058; 0.221] | 1.15 |
Extrahepatic bilary tract | |||||
Mesothelioma | < 0.025 | < 0.05 | 0.057 | [-0.172; 0.052] | |
Small intestine | 0.69 | < 0.05 | 0.009 | [-0.127; 0.135] |